Omni 360 Wealth’s T. Rowe Price US Equity Research ETF TSPA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$314K Buy
6,500
+420
+7% +$20.1K 0.14% 115
2026
Q2
$289K Buy
6,080
+380
+7% +$17.4K 0.13% 111
2026
Q1
$233K Buy
5,700
+40
+0.7% +$1.71K 0.12% 117
2025
Q4
$245K Hold
5,660
– – 0.13% 114
2025
Q3
$237K Sell
5,660
-1,000
-15% -$40.3K 0.13% 112
2025
Q2
$259K Buy
6,660
+100
+2% +$3.6K 0.16% 102
2025
Q1
$231K Buy
6,560
+80
+1% +$2.96K 0.15% 101
2024
Q4
$240K Buy
6,480
+820
+14% +$30.4K 0.16% 100
2024
Q3
$204K Buy
+5,660
New +$197K 0.14% 108

Other funds holding TSPA

Omni 360 Wealth's TSPA Position: Q3 2026 in Review

Omni 360 Wealth increased its T. Rowe Price US Equity Research ETF (TSPA) stake by 6.9% in Q3 2026, buying an estimated $20.1K and bringing the position to 6,500 shares worth $314K. The position accounts for 0.14% of the portfolio, ranked #115.

Omni 360 Wealth first reported a position in TSPA in Q3 2024 and has held it in 9 quarters since. 72 funds tracked by Wall St. Rank hold TSPA as of Q3 2026.

  • Omni 360 Wealth held 6,500 shares of T. Rowe Price US Equity Research ETF worth $314K as of Q3 2026.
  • Omni 360 Wealth bought 420 T. Rowe Price US Equity Research ETF shares in Q3 2026, an estimated $20.1K.
  • T. Rowe Price US Equity Research ETF made up 0.14% of Omni 360 Wealth's portfolio in Q3 2026, its #115 holding.
  • Omni 360 Wealth first reported a position in T. Rowe Price US Equity Research ETF in Q3 2024 and has held it in 9 quarters since.
  • 72 funds tracked by Wall St. Rank held T. Rowe Price US Equity Research ETF as of Q3 2026.

Based on Omni 360 Wealth's 13F filing for Q3 2026, filed 13 Oct 2026.